“Genotype-Related Efficacy and Adverse Effects of Selective Serotonin Reuptake Inhibitors in Patients with Major Depressive Disorder”, Precis. Med. Com., vol. 2, no. 1, pp. 27–42, Jun. 2022, doi: 10.55627/pmc.002.01.0044.